|Bid||71.84 x 1200|
|Ask||71.85 x 800|
|Day's Range||71.66 - 73.40|
|52 Week Range||51.80 - 73.75|
|Beta (3Y Monthly)||0.26|
|PE Ratio (TTM)||51.72|
|Earnings Date||Oct 24, 2019 - Oct 28, 2019|
|Forward Dividend & Yield||3.17 (4.36%)|
|1y Target Est||69.16|
Ventas, Inc. (VTR) (“Ventas” or the “Company”) announced today the expiration and results of the previously announced offer by Ventas Realty, Limited Partnership (“Ventas Realty”) and Ventas Capital Corporation (“Ventas Capital” and, together with Ventas Realty, the “Issuers”), its wholly owned subsidiaries, to purchase for cash (the “Tender Offer”) any and all of their outstanding 4.25% Senior Notes due 2022 (the “Notes”), jointly issued by the Issuers and fully and unconditionally guaranteed by Ventas, which expired at 5:00 p.m., New York City time, on August 16, 2019 (the “Expiration Time”).
EVP, Chief Investment Off. of Ventas Inc (30-Year Financial, Insider Trades) John D. Cobb (insider trades) sold 10,000 shares of VTR on 08/15/2019 at an average price of $72.54 a share. Continue reading...
Ventas, Inc. (VTR) (“Ventas” or the “Company”) announced today that it has priced a public offering of $650 million aggregate principal amount of 3.000% Senior Notes due 2030 (the “Notes”) at 99.506% of the principal amount. The Notes are being issued by Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of the Company, and will be guaranteed, on a senior unsecured basis, by the Company. The Company expects to use the net proceeds from the offering, together with cash on hand and/or borrowings under the Company’s unsecured revolving credit facility, to purchase Ventas Realty’s 4.25% Senior Notes due 2022 pursuant to a cash tender offer for any and all of such notes (the “Tender Offer”) that Ventas Realty commenced today.
Ventas, Inc. announced today that Ventas Realty, Limited Partnership and Ventas Capital Corporation , its wholly owned subsidiaries, have commenced a cash tender offer for any and all of their outstanding 4.25% Senior Notes due 2022 (CUSIP No.
HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Ventas Inc. New York, July 26, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Ventas Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Ventas' (VTR) Q2 results display stellar revenues from office and triple net leased portfolio, while its impressive 1H19 performance encourages management to raise the guidance for the ongoing year.
Ventas (VTR) delivered FFO and revenue surprises of 1.04% and 1.50%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Ventas, Inc. (VTR) announced that Sean P. Nolan, former Chief Executive Officer of AveXis, Inc. (formerly NASDAQ: AVXS), a clinical-stage gene therapy company, has been appointed as an independent member of its Board of Directors, effective as of today. “Sean is an incredible addition to our diverse, experienced and independent Board of Directors,” said Debra A. Cafaro, Ventas Chairman and CEO. “Ventas is a powerful platform with expansive opportunities, and I’m delighted to join the Company’s excellent Board,” said Mr. Nolan.
PS Business Parks' (PSB) Q2 performance reflects growth in Same-Park NOI, backed by growth in rental rates, as well as higher NOI from non-Same-Park and multi-family assets.
Optimism in the U.S housing market has likely provided AGNC Investment (AGNC) with opportunities in the securitized mortgage securities market. Yet, high financing costs will likely impact Q2 results.
Since majority of Blackstone Mortgage's (BXMT) loan portfolio earns a floating rate of interest, a decline in LIBOR rates during Q2 will likely impact portfolio yields unfavorably.